Stability Monitoring Frequency Over 36-Month Study Period
Stability Monitoring Frequency Over 36-Month Study Period Designing a Stability Monitoring Schedule Across 36 Months: Frequency Guidelines and Regulatory Best Practices A robust pharmaceutical stability program doesn’t just hinge on the conditions of testing—it also relies heavily on the timing of sample pull points. Regulatory agencies including the FDA, EMA, and WHO expect structured, risk-based…
Read More “Stability Monitoring Frequency Over 36-Month Study Period” »